ID   CERT_HUMAN              Reviewed;         752 AA.
AC   Q9Y5P4-3;
DT   15-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   12-OCT-2022, entry version 193.
DE   RecName: Full=Isoform 3 of Ceramide transfer protein {ECO:0000303|PubMed:14685229, ECO:0000305};
DE            Short=hCERT {ECO:0000303|PubMed:14685229};
DE   AltName: Full=Collagen type IV alpha-3-binding protein {ECO:0000305};
DE   AltName: Full=Goodpasture antigen-binding protein {ECO:0000303|PubMed:10212244};
DE            Short=GPBP;
DE   AltName: Full=START domain-containing protein 11;
DE            Short=StARD11;
DE   AltName: Full=StAR-related lipid transfer protein 11;
GN   Name=CERT1 {ECO:0000312|HGNC:HGNC:2205};
GN   Synonyms=CERT, COL4A3BP {ECO:0000312|HGNC:HGNC:2205}, STARD11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHARACTERIZATION.
RX   PubMed=10212244; DOI=10.1074/jbc.274.18.12642;
RA   Raya A., Revert F., Navarro S., Saus J.;
RT   "Characterization of a novel type of serine/threonine kinase that
RT   specifically phosphorylates the human goodpasture antigen.";
RL   J. Biol. Chem. 274:12642-12649(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=11007769; DOI=10.1074/jbc.m002769200;
RA   Raya A., Revert-Ros F., Martinez-Martinez P., Navarro S., Rosello E.,
RA   Vieites B., Granero F., Forteza J., Saus J.;
RT   "Goodpasture antigen-binding protein, the kinase that phosphorylates the
RT   Goodpasture antigen, is an alternatively spliced variant implicated in
RT   autoimmune pathogenesis.";
RL   J. Biol. Chem. 275:40392-40399(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, AND DOMAIN START.
RX   PubMed=14685229; DOI=10.1038/nature02188;
RA   Hanada K., Kumagai K., Yasuda S., Miura Y., Kawano M., Fukasawa M.,
RA   Nishijima M.;
RT   "Molecular machinery for non-vesicular trafficking of ceramide.";
RL   Nature 426:803-809(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Lung, and Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-77.
RA   Ogi T., Yamamoto Y., Ohmori H.;
RT   "Homo sapiens genomic sequence, containing DINB1 and GPBP gene.";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   INTERACTION WITH VAPA AND VAPB, SUBCELLULAR LOCATION, MUTAGENESIS OF
RP   ASP-324, DOMAIN FFAT MOTIF, AND DOMAIN PH.
RX   PubMed=16895911; DOI=10.1074/jbc.m605032200;
RA   Kawano M., Kumagai K., Nishijima M., Hanada K.;
RT   "Efficient trafficking of ceramide from the endoplasmic reticulum to the
RT   Golgi apparatus requires a VAMP-associated protein-interacting FFAT motif
RT   of CERT.";
RL   J. Biol. Chem. 281:30279-30288(2006).
RN   [11]
RP   PHOSPHORYLATION AT SER-132, FUNCTION, AND MUTAGENESIS OF SER-132.
RX   PubMed=17591919; DOI=10.1083/jcb.200612017;
RA   Fugmann T., Hausser A., Schoeffler P., Schmid S., Pfizenmaier K.,
RA   Olayioye M.A.;
RT   "Regulation of secretory transport by protein kinase D-mediated
RT   phosphorylation of the ceramide transfer protein.";
RL   J. Cell Biol. 178:15-22(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-377, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   PHOSPHORYLATION BY CSNK1G2/CK1.
RX   PubMed=19005213; DOI=10.1091/mbc.e08-07-0669;
RA   Tomishige N., Kumagai K., Kusuda J., Nishijima M., Hanada K.;
RT   "Casein kinase I{gamma}2 down-regulates trafficking of ceramide in the
RT   synthesis of sphingomyelin.";
RL   Mol. Biol. Cell 20:348-357(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-126; TYR-372; SER-373 AND
RP   SER-380, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   INVOLVEMENT IN MRD34, AND VARIANT MRD34 LEU-132.
RX   PubMed=25533962; DOI=10.1038/nature14135;
RG   Deciphering Developmental Disorders Study;
RT   "Large-scale discovery of novel genetic causes of developmental
RT   disorders.";
RL   Nature 519:223-228(2015).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH MOSPD2, SUBCELLULAR
RP   LOCATION, DOMAIN, FFAT MOTIF, AND MUTAGENESIS OF ASP-324.
RX   PubMed=29858488; DOI=10.15252/embr.201745453;
RA   Di Mattia T., Wilhelm L.P., Ikhlef S., Wendling C., Spehner D., Nomine Y.,
RA   Giordano F., Mathelin C., Drin G., Tomasetto C., Alpy F.;
RT   "Identification of MOSPD2, a novel scaffold for endoplasmic reticulum
RT   membrane contact sites.";
RL   EMBO Rep. 19:0-0(2018).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 347-624 IN COMPLEXES WITH
RP   CERAMIDES AND DIACYLGLYCEROL, MUTAGENESIS OF GLU-472; GLN-493 AND ASN-530,
RP   FUNCTION, SUBCELLULAR LOCATION, AND CERAMIDE-BINDING.
RX   PubMed=18184806; DOI=10.1073/pnas.0709191105;
RA   Kudo N., Kumagai K., Tomishige N., Yamaji T., Wakatsuki S., Nishijima M.,
RA   Hanada K., Kato R.;
RT   "Structural basis for specific lipid recognition by CERT responsible for
RT   nonvesicular trafficking of ceramide.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:488-493(2008).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.66 ANGSTROMS) OF 347-624 IN COMPLEXES WITH
RP   CERAMIDE AND INHIBITOR, MUTAGENESIS OF TRP-499, FUNCTION, AND
RP   CERAMIDE-BINDING.
RX   PubMed=20036255; DOI=10.1016/j.jmb.2009.12.029;
RA   Kudo N., Kumagai K., Matsubara R., Kobayashi S., Hanada K., Wakatsuki S.,
RA   Kato R.;
RT   "Crystal structures of the CERT START domain with inhibitors provide
RT   insights into the mechanism of ceramide transfer.";
RL   J. Mol. Biol. 396:245-251(2010).
RN   [22]
RP   VARIANT CYS-138.
RX   PubMed=23033978; DOI=10.1056/nejmoa1206524;
RA   de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G.,
RA   Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P., Gilissen C.,
RA   del Rosario M., Hoischen A., Scheffer H., de Vries B.B., Brunner H.G.,
RA   Veltman J.A., Vissers L.E.;
RT   "Diagnostic exome sequencing in persons with severe intellectual
RT   disability.";
RL   N. Engl. J. Med. 367:1921-1929(2012).
RN   [23]
RP   VARIANT MRD34 ARG-243.
RX   PubMed=25356899; DOI=10.1371/journal.pgen.1004772;
RA   Hamdan F.F., Srour M., Capo-Chichi J.M., Daoud H., Nassif C., Patry L.,
RA   Massicotte C., Ambalavanan A., Spiegelman D., Diallo O., Henrion E.,
RA   Dionne-Laporte A., Fougerat A., Pshezhetsky A.V., Venkateswaran S.,
RA   Rouleau G.A., Michaud J.L.;
RT   "De novo mutations in moderate or severe intellectual disability.";
RL   PLoS Genet. 10:E1004772-E1004772(2014).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=CERTL {ECO:0000303|PubMed:14685229};
CC         IsoId=Q9Y5P4-1; Sequence=Displayed;
CC       Name=2; Synonyms=Delta26, GPBPD26, CERT {ECO:0000303|PubMed:14685229};
CC         IsoId=Q9Y5P4-2; Sequence=VSP_006276;
CC       Name=3;
CC         IsoId=Q9Y5P4-3; Sequence=VSP_041022;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS47235.1; -.
DR   RefSeq; NP_001123577.1; NM_001130105.1.
DR   ProteomicsDB; 86465; -.
DR   Ensembl; ENST00000405807.10; ENSP00000383996.4; ENSG00000113163.19.
DR   Proteomes; UP000005640; Chromosome 5.
PE   1: Evidence at protein level;
SQ   SEQUENCE   752 AA;  83708 MW;  277A14A581D94EDF CRC64;
     MQHSCIPTPP SPFSAPPAFL PVVTRESRRG LSSGGSAGRN AGVTATAAAA DGWKGRLPSP
     LVLLPRSARC QARRRRGGRT SSLLLLPPTP ERALFASPSP DPSPRGLGAS SGAAEGAGAG
     LLLGCRASMS DNQSWNSSGS EEDPETESGP PVERCGVLSK WTNYIHGWQD RWVVLKNNAL
     SYYKSEDETE YGCRGSICLS KAVITPHDFD ECRFDISVND SVWYLRAQDP DHRQQWIDAI
     EQHKTESGYG SESSLRRHGS MVSLVSGASG YSATSTSSFK KGHSLREKLA EMETFRDILC
     RQVDTLQKYF DACADAVSKD ELQRDKVVED DEDDFPTTRS DGDFLHSTNG NKEKLFPHVT
     PKGINGIDFK GEAITFKATT AGILATLSHC IELMVKREDS WQKRLDKETE KKRRTEEAYK
     NAMTELKKKS HFGGPDYEEG PNSLINEEEF FDAVEAALDR QDKIEEQSQS EKVRLHWPTS
     LPSGDAFSSV GTHRFVQKPY SRSSSMSSID LVSASDDVHR FSSQVEEMVQ NHMTYSLQDV
     GGDANWQLVV EEGEMKVYRR EVEENGIVLD PLKATHAVKG VTGHEVCNYF WNVDVRNDWE
     TTIENFHVVE TLADNAIIIY QTHKRVWPAS QRDVLYLSVI RKIPALTEND PETWIVCNFS
     VDHDSAPLNN RCVRAKINVA MICQTLVSPP EGNQEISRDN ILCKITYVAN VNPGGWAPAS
     VLRAVAKREY PKFLKRFTSY VQEKTAGKPI LF
//
